Literature DB >> 15848277

Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis.

Viviane Mazo Fávero Gimenes1, Maria Da Glória de Souza, Karen Spadari Ferreira, Sirley G Marques, Azizedite Guedes Gonçalves, Daniel Vagner de Castro Lima Santos, Conceição de Maria Pedroso e Silva, Sandro Rogério Almeida.   

Abstract

Chromoblastomycosis is a chronic, often debilitating, suppurative, granulomatus mycosis of the skin and subcutaneous tissues beginning after inoculation trauma. It occurs world-wide, but is more frequently observed in tropical countries such as Brazil. The disease is usually insidious, and the lesions increase slowly but progressively, not responding to the usual treatments and quite often reappearing. The host defense mechanism in chromoblastomycosis has not been extensively investigated. Some studies have focused on fungus-host interaction, showing a predominantly cellular immune response, with the activation of macrophages involved in fungus phagocytosis. Although phagocytosis did occur, death of fungal cells was rarely observed. The ability of Fonsecaea pedrosoi to produce secreted or cell wall-associated melanin-like components, protects against destruction by host immune cells in vitro. Until now, the T cell immune response in chromoblastomycosis is undefined. In the present work, it was shown that, in patients with the severe form of the disease, predominant production of IL-10 cytokine, low levels of IFN-gamma and inefficient T cell proliferation were induced. In contrast, in patients with a mild form of the disease, predominant production of IFN-gamma cytokine, low levels of IL-10 and efficient T cell proliferation were observed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848277     DOI: 10.1016/j.micinf.2005.01.006

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  31 in total

Review 1.  Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Authors:  Seyedmojtaba Seyedmousavi; Mihai G Netea; Johan W Mouton; Willem J G Melchers; Paul E Verweij; G Sybren de Hoog
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Subcutaneous fungal infections.

Authors:  Ricardo M La Hoz; John W Baddley
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

3.  The cell wall fraction from Fonsecaea pedrosoi stimulates production of different profiles of cytokines and nitric oxide by murine peritoneal cells in vitro.

Authors:  Yanna Karla de Medeiros Nóbrega; Viviane Furlan Lozano; Tarciane Silva de Araújo; Daniel Diniz de Carvalho; Anamélia Lorenzetti Bocca
Journal:  Mycopathologia       Date:  2010-03-30       Impact factor: 2.574

4.  Melanin in a meristematic mutant of Fonsecaea monophora inhibits the production of nitric oxide and Th1 cytokines of murine macrophages.

Authors:  Junmin Zhang; Li Wang; Liyan Xi; Huaiqiu Huang; Yongxuan Hu; Xiqing Li; Xiao Huang; Sha Lu; Jiufeng Sun
Journal:  Mycopathologia       Date:  2012-10-03       Impact factor: 2.574

Review 5.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media.

Authors:  Valeriano Antonio Corbellini; Maria Lúcia Scroferneker; Mariana Carissimi; Luciane Domingues Santolin
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

7.  Fungal x host interactions in Chromoblastomycosis: what we have learned from animal models and what is yet to be solved.

Authors:  Claudio Guedes Salgado
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

8.  Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+ T cell activation in vitro.

Authors:  M Glória Sousa; E Eid Bou Ghosn; R Ciciro Nascimento; G Facchioli Bomfim; V Noal; K Santiago; C de Maria Pedrozo E Silva Azevedo; S Garcia Marques; A Guedes Gonçalves; D Wagner de Castro Lima Santos; P Ricardo Criado; J Eduardo Costa Martins; S Rogerio Almeida
Journal:  Clin Exp Immunol       Date:  2009-02-04       Impact factor: 4.330

9.  Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin.

Authors:  Anamelia L Bocca; Patrícia P M S Brito; Florêncio Figueiredo; Carlos Eduardo Tosta
Journal:  Mycopathologia       Date:  2006-04       Impact factor: 2.574

10.  DNA-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by Fonsecaea pedrosoi.

Authors:  Isaque Medeiros Siqueira; Alice Melo Ribeiro; Yanna Karla de Medeiros Nóbrega; Karina Smidt Simon; Ana Camila Oliveira Souza; Márcio Souza Jerônimo; Florêncio Figueiredo Cavalcante Neto; Célio Lopes Silva; Maria Sueli Soares Felipe; Anamélia Lorenzetti Bocca
Journal:  Mycopathologia       Date:  2012-11-22       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.